Wed, Apr 16, 2014, 3:39 AM EDT - U.S. Markets open in 5 hrs 51 mins

Recent

% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • showupplax showupplax Aug 24, 2006 4:02 PM Flag

    "EPCT" MORE NEW HIGHS COMING??

    Today's spike might end up meaning nothing...

    EPCT is currently trading around its 50-day moving average and what it needs to do is find a way to reverse the current trend (by staging a solid move on above average volume). This move above the current support level might convince others that the stock might be turning around. But volume is key here because it has to be above average, a sign that institutions are jumping in.
    $3.72 IS THE CURRENT 200-DAY MOVING AVERAGE PRICE AND A MOVE THERE WOULD BE VERY BULLISH.

    Will EPCT be among the top 50 percentage gainers over the next 9 - 12 months??

    9-Month price target??
    Good luck!!

    Also keep an eye on the following timely MOMENTUM purchases; BTJ, NGPS, ORCL EZM, and NUVO...

    -----
    -----
    -----
    -----
    -----
    -----
    -----
    -----
    -----
    -----
    -----

    Find your next stock market winner... It is true that 70%, 87% and 71% of the TOP 50 STOCKS of 2003, 2004 and 2005 respectively were profiled to members before they made their initial moves!!

    Don't worry about losing money since ALL STOCK PICKS COME WITH A 5% - 10% STOP LOSS ORDER STRATEGY. If you have a few dollars to spare a month then you owe it to yourself to try this service ...GOOD LUCK IN 2006!! BULLISH IN 2007!!

    ***** Click on my userid (username) then on the cool link for the site *****

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IMNP
3.94-0.22(-5.29%)Apr 15 3:58 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.